Real-world use of nirmatrelvir-ritonavir: who benefits?

被引：1
|
作者：
Molina, Kyle C. [1 ,2 ]
Ginde, Adit A. [1 ]
机构：
[1] Colorado Univ, Dept Emergency Med, Sch Med, Aurora, CO 80045 USA
[2] Scripps Hlth, La Jolla, CA 92037 USA
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S1473-3099(23)00180-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [1] Real-world use of nirmatrelvir-ritonavir: who benefits? (VOL 23, pg e122, 2023)
    Molina, K. C.
    Ginde, A. A.
    LANCET INFECTIOUS DISEASES, 2023, 23 (05): : E166 - E166
  • [2] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
    Zeng, Guangting
    Wang, Linlin
    Li, Jianqiang
    Zhang, Zanling
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [3] Nirmatrelvir-ritonavir and simvastatine
    Legeay, Samuel
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (630): : 17 - 19
  • [4] Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19
    Jang, Young Rock
    Oh, Yoonju
    Kim, Jin Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (06)
  • [5] Benefits of nirmatrelvir-ritonavir remain unproven for some populations
    McDonald, Emily G.
    Lee, Todd
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (29) : E1041 - E1041
  • [6] Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
    Kim, Min-Kyung
    Lee, Kyung-Shin
    Ham, Sin Young
    Choi, Youn Young
    Lee, Eunyoung
    Lee, Seungjae
    Lee, Bora
    Jeon, Jaehyun
    Chin, Bumsik
    Kim, Yeonjae
    Kim, Gayeon
    Jang, Hee -Chang
    Choi, Jae-Phil
    Park, Sang -Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (35)
  • [7] Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir-Ritonavir: Real-World Data Analysis
    Weil, Clara
    Tene, Lilac
    Chodick, Gabriel
    Fallach, Noga
    Ansari, Wajeeha
    Distelman-Menachem, Tal
    Maor, Yasmin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [8] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study
    Deng, Guangtong
    Li, Daishi
    Sun, Yuming
    Jin, Liping
    Zhou, Qian
    Xiao, Chenggen
    Wu, Qingrong
    Sun, Huiyan
    Dian, Yating
    Zeng, Furong
    Pan, Pinhua
    Shen, Minxue
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [9] Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients
    Zaharuddin, Zahirah
    Hussin, Nur Sabiha Md
    Karuppannan, Mahmathi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes
    Su, Guanyue
    Li, Silin
    Zhang, Donghua
    Zhou, Yongjian
    Wang, Ling
    Yuan, Yiqiang
    Qian, Guowu
    Li, Guotao
    Han, Na
    Cheng, Ming
    Li, Guangming
    Zhang, Shixi
    Luo, Hong
    Yang, Mengzhao
    Zhang, Yanyang
    Song, Zhan
    Xing, Jiyuan
    Yu, Zujiang
    Ren, Zhigang
    ISCIENCE, 2025, 28 (02)
12345